PP04A

Oncology – intratumoral STING agonist

PreclinicalActive

Key Facts

Indication
Oncology – intratumoral STING agonist
Phase
Preclinical
Status
Active
Company

About PolyPid

PolyPid delivers precision, long‑acting drug depots via its Kynatrix™ platform to improve outcomes in surgery, metabolism and cancer.

View full company profile